Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk

Cancer Research

Volumn 69, Issue 4, 2009, Pages 1429-1438

  Wright, Margaret E ^a   Peters, Ulrike ^b   Gunter, Marc J ^c   Moore, Steven C ^d   Lawson, Karla A ^e   Yeager, Meredith ^d   Weinstein, Stephanie J ^d   Snyder, Kirk ^f   Virtamo, Jarmo ^g   Albanes, Demetrius ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e DELL CHILDREN S MEDICAL CENTER OF CENTRAL TEXAS   (United States)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ONCOPROTEIN; PROTEIN SEC14L2; PROTEIN TTPA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; BETA CAROTENE; CARRIER PROTEINS; DIET; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GENETIC VARIATION; HUMANS; LIPOPROTEINS; MALE; MEAT; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TRANS-ACTIVATORS; VITAMIN E;

EID: 60549112413     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2343     Document Type: Article

References (36)

1. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with α-tocopherol and beta;-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
2. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:893-9.
3. Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, β-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006;98:245-54.
4. Rodriguez C, Jacobs EJ, Mondul AM, Calle EE, McCullough ML, Thun MJ. Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 2004;13:378-82.
5. Wright ME, Weinstein SJ, Lawson KA, et al. Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2007;16:1128-35.
6. Klein EA, Thompson IM, Lippman SM, et al. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis 2000;3:145-51.
7. Freeman VL, Meydani M, Yong S, et al. Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. Am J Epidemiol 2000;151:109-18.
8. Arita M, SatoY,Miyata A, et al. Human α-tocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem J 1995;306:437-43.
9. Hosomi A, Arita M, Sato Y, et al. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBSLett 1997;409:105-8.
10. Ouahchi K, Arita M, Kayden H, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nat Genet 1995;9:141-5.
11. Zimmer S, Stocker A, Sarbolouki MN, Spycher SE, Sassoon J, Azzi A. A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem 2000;275:25672-80.
12. Yamauchi J, Iwamoto T, Kida S, Masushige S, Yamada K, Esashi T. Tocopherol-associated protein is a ligand-dependent transcriptional activator. Biochem Biophys Res Commun 2001;285:295-9.
13. Kempna P, Zingg JM, Ricciarelli R, Hierl M, Saxena S, Azzi A. Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. Free Radic Biol Med 2003;34:1458-72.
14. Shibata N, Arita M, Misaki Y, et al. Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis. Proc Natl Acad Sci U S A 2001;98:2244-9.
15. Shibata N, Jishage K, Arita M, et al. Regulation of hepatic cholesterol synthesis by a novel protein (SPF) that accelerates cholesterol biosynthesis. FASEB J 2006;20:2642-4.
16. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10.
17. Milne DB, Botnen J. Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986;32:874-6.
18. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002;41:381-8.
19. American Joint Committee on Cancer. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott; 1992.
20. Sherry ST, Ward M, Sirotkin K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 1999;9:677-9.
21. Woodson K, Ratnasinghe D, Bhat NK, et al. Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. Eur J Cancer Prev 1999;8:441-7.
22. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
23. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
24. Schaid DJ. Evaluating associations of haplotypes with traits. Genet Epidemiol 2004;27:348-64.
25. Cavalier L, Ouahchi K, Kayden HJ, et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet 1998;62:301-10.
26. Wu CG, Hoek FJ, Groenink M, Reitsma PH, van Deventer SJ, Chamuleau RA. Correlation of repressed transcription of α-tocopherol transfer protein with serum α-tocopherol during hepatocarcinogenesis. Int J Cancer 1997;71:686-90.
27. Ni J, Wen X, Yao J, et al. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 2005;65:9807-16.
28. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
29. Ebrahim S, Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observationalepidemiology? Hum Genet 2008;123:15-33.
30. Weinstein SJ, Wright ME, Lawson KA, et al. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1253-9.
31. Borel P, Moussa M, Reboul E, et al. Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr 2007;137:2653-9.
32. Hacquebard M, Carpentier YA. Vitamin E: absorption, plasma transport and cell uptake. Curr Opin Clin Nutr Metab Care 2005;8:133-8.
33. Pastori M, Pfander H, Boscoboinik D, Azzi A. Lycopene in association with α-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells. Biochem Biophys Res Commun 1998;250:582-5.
34. Venkateswaran V, Fleshner NE, Klotz LH. Synergistic effect ofvitamin E and selenium in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 2004;7:54-6.
35. Kere J. Human population genetics: lessons from Finland. Annu Rev Genomics Hum Genet 2001;2:103-28.
36. Bruno RS, Traber MG. Cigarette smoke alters human vitamin E requirements. J Nutr 2005;135:671-4.